Rhythm Wins Reimbursement For Obesity Drug Imcivree In France & England

France is set to become the first country in Europe to fund Imcivree for a second – and as yet unapproved – indication. Meanwhile, England has agreed to reimburse the drug for its approved indication as did Germany earlier this year. Reimbursement discussions are underway in the rest of Europe.

More patients in Europe will get access to Imcivree for obesity • Source: Alamy

More from Market Access

More from Pink Sheet